Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Neural Transm (Vienna) ; 126(12): 1599-1608, 2019 12.
Article in English | MEDLINE | ID: mdl-31673927

ABSTRACT

C-reactive protein (CRP) is a biomarker of systemic inflammation that has been linked to accelerated decline in walking speed in older adults. The aim of the present study was to compare the CRP levels of PD patients with vs patients without freezing of gait (FOG). Patients and controls participating in the COPPADIS-2015 study that performed blood extraction for determining molecular serum biomarkers were included. Patients with FOG were identified as those with a score of 1 or greater on item-3 of the Freezing of Gait Questionnaire (FOG-Q). Immunoassay was used for determining ultrasensitive CRP (US-CRP) level (mg/dL). In the PD group (n = 225; 61.8 ± 9.5 years old, 61.8% males), 32% of the patients presented FOG but none in the control group (n = 65; 60.3 ± 6.1 years old, 56.9% males) (p < 0.0001). Differences in US-CRP level were significant in patients with FOG vs patients without FOG and vs controls (0.31 ± 0.52 vs 0.16 ± 0.21 vs 0.21 ± 0.22; p = 0.04). Significant differences were also observed between patients with vs without FOG (p = 0.001) but not between patients and controls (p = 0.163). US-CRP level was related to FOG (OR = 4.369; 95% CI 1.105-17.275; p = 0.036) along with H&Y (OR = 2.974; 95% CI 1.113-7.943; p = 0.030) and non-motor symptoms burden (NMSS total score; OR = 1.017; 95% CI 1.005-1.029; p = 0.006) after adjusting for age, gender, disease duration, equivalent daily levodopa dose, number of non-antiparkinsonian drugs per day, motor fluctuations, cognition, motor phenotype, and chronic use of anti-inflammatory drugs. The present study suggests that serum US-CRP level is related to FOG in PD patients. Inflammation could be linked to FOG development.


Subject(s)
Biomarkers/blood , C-Reactive Protein/analysis , Gait Disorders, Neurologic/blood , Parkinson Disease/blood , Aged , Female , Gait Disorders, Neurologic/etiology , Humans , Male , Middle Aged , Parkinson Disease/complications
2.
Respir Res ; 19(1): 72, 2018 04 24.
Article in English | MEDLINE | ID: mdl-29690880

ABSTRACT

BACKGROUND: Radiation pneumonitis (RP) is a frequent complication of concurrent chemoradiotherapy (CCRT) and is associated with severe symptoms that decrease quality of life and might result in pulmonary fibrosis or death. The aim of this study is to identify whether pulmonary function test (PFT) abnormalities may predict RP in non-small cell lung cancer (NSCLC) patients. METHODS: A prospective multi-institutional study was conducted with locally advanced and oligometastatic NSCLC patients. All participants were evaluated at baseline, end of CCRT, week 6, 12, 24, and 48 post-CCRT. They completed forced spirometry with a bronchodilator, body plethysmography, impulse oscillometry, carbon monoxide diffusing capacity (DLCO), molar mass of CO2, six-minute walk test and exhaled fraction of nitric oxide (FeNO). Radiation pneumonitis was assessed with RTOG and CTCAE. The protocol was registered in www.clinicaltrials.gov (NCT01580579), registered April 19, 2012. RESULTS: Fifty-two patients were enrolled; 37 completed one-year follow-up. RP ≥ Grade 2 was present in 11/37 (29%) for RTOG and 15/37 (40%) for CTCAE. Factors associated with RP were age over 60 years and hypofractionated dose. PFT abnormalities at baseline that correlated with the development of RP included lower forced expiratory volume in one second after bronchodilator (p = 0.02), DLCO (p = 0.02) and FeNO (p = 0.04). All PFT results decreased after CCRT and did not return to basal values at follow-up. CONCLUSIONS: FEV1, DLCO and FeNO prior to CCRT predict the development of RP in NSCLC. This study suggests that all patients under CCRT should be assessed by PFT to identify high-risk patients for close follow-up and early treatment.


Subject(s)
Carcinoma, Non-Small-Cell Lung/radiotherapy , Forced Expiratory Volume/physiology , Lung Neoplasms/radiotherapy , Radiation Pneumonitis/diagnosis , Spirometry/trends , Age Factors , Carcinoma, Non-Small-Cell Lung/physiopathology , Cohort Studies , Female , Follow-Up Studies , Humans , Lung Neoplasms/physiopathology , Male , Predictive Value of Tests , Prospective Studies , Radiation Pneumonitis/physiopathology , Respiratory Function Tests/trends
3.
Chem Rec ; 18(7-8): 1085-1104, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29485231

ABSTRACT

Porous clay heterostructures (PCH) are obtained by the insertion of an organic bulky cation in the interlayer spacing of a smectite, causing a swelling of the clay mineral. Right after, oxides species, mainly silicon oxide, are incorporated as pillars galleries between adjacent layers to form a porous structure after the removal of the template. The ordering of the clay mineral as well the organic cation incorporated in the synthetic step favors the modulation of the textural properties of the PCH. In addition, the incorporation of heteroatoms in the pillars galleries can also modulate the acidity of the PCH. The modulation of the pore size and the acid properties provides to these materials a wide range of applications in the fields of adsorption and catalysis. This paper carries out a detailed review of the synthesis of PCH, characterization as well as uses and application reported in the literature.

4.
Rev Port Pneumol (2006) ; 23(1): 27-30, 2017.
Article in English | MEDLINE | ID: mdl-28043788

ABSTRACT

Diabetes mellitus (DM) is a well-known risk factor for tuberculosis (TB). However, it is not known to what extent DM affects the outcome in patients with multidrug-resistant (MDR-TB) and extensively drug-resistant TB (XDR-TB) treated with second-line anti-TB drugs. The objective of this study was to compare the microbiological evolution (sputum smear and culture conversion) and final outcomes of MDR/XDR-TB patients with and without DM, managed at the national TB reference centre in Mexico City. RESULTS: Ninety patients were enrolled between 2010 and 2015: 73 with MDR-TB (81.1%), 11 with pre-XDR-TB (e.g. MDR-TB with additional resistance to one injectable drug or a fluoroquinolone, 12.2%) and 6 (6.7%) with XDR-TB. Out of these, 49 (54.4%) had DM and 42 (86%) were undergoing insulin treatment. No statistically significant differences were found in treatment outcomes comparing DM vs. non-DM MDR-TB cases: 18/32 (56.3%) of DM cases and 19/24 (79.2%) non DM patients achieved treatment success (p=0.07). The time to sputum smear and culture conversion was longer (although not statistically) in patients without DM, as follows: the mean (±SD) time to sputum smear conversion was 53.9 (±31.4) days in DM patients and 65.2 (±34.8) days in non-DM ones (p=0.15), while the time to culture conversion was 66.2 (±27.6) days for DM and 81.4 (±37.7) days for non-DM MDR-TB cases (p=0.06). CONCLUSIONS: The study results support the Mexican National TB programme to strengthen its collaboration with the DM programme, as an entry point for TB (and latent TB infection) screening and management.


Subject(s)
Antitubercular Agents/pharmacology , Antitubercular Agents/therapeutic use , Diabetes Complications/microbiology , Mycobacterium tuberculosis/drug effects , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/microbiology , Diabetes Complications/drug therapy , Extensively Drug-Resistant Tuberculosis/complications , Extensively Drug-Resistant Tuberculosis/drug therapy , Extensively Drug-Resistant Tuberculosis/microbiology , Humans , Mexico , Mycobacterium tuberculosis/isolation & purification , Sputum/microbiology , Treatment Outcome , Tuberculosis, Multidrug-Resistant/complications
5.
Rev. neurol. (Ed. impr.) ; 54(supl.4): s1-s12, 3 oct., 2012. ilus
Article in Spanish | IBECS | ID: ibc-150513

ABSTRACT

Introducción. Los síndromes rígido-acinéticos incluyen un grupo heterogéneo de patologías agrupados por una serie de síntomas comunes en las esferas motora, cognitiva y emocional. Desarrollo. Los ganglios basales están constituidos por un grupo de estructuras anatómicamente dispersas que se conectan entre sí y con diversas estructuras formando un entramado de redes funcionales. Las lesiones en estos circuitos producen síntomas en las esferas motora, cognitiva y emocional. En la enfermedad de Parkinson, el síndrome rígido-acinético más conocido y estudiado, actualmente sólo pueden explicarse del conjunto de sus síntomas el temblor y la bradicinesia. Los síndromes rígido-acinéticos se consideran hoy enfermedades neurodegenerativas que afectan a múltiples estructuras y sistemas del sistema nervioso central y periférico. Una gran parte de estos pueden agruparse dentro de las sinucleinopatías y las taupatías, aunque en ocasiones los hallazgos anatomopatológicos entre ambas se solapan. Conclusiones. Es preciso un mayor conocimiento del funcionamiento del sistema nervioso y los procesos de degeneración neuronal para poder obtener nuevas estrategias terapéuticas más eficaces (AU)


Introduction. The rigid-akinetic syndromes include a heterogeneous collection of pathologies grouped by a series of common symptoms that appear in the motor, cognitive and emotional spheres. Development. The basal ganglia are made up of a group of anatomically dispersed structures that are nonetheless connected to each other and with several other structures to form a cluster of functional networks. Lesions in these circuits produce symptoms in the motor, cognitive and emotional spheres. Of all the syndromes that occur in Parkinson's disease, which is the best-known and most widely studied rigid-akinetic syndrome, only tremor and bradykinesia can presently be explained. Rigid-akinetic syndromes are nowadays considered to be neurodegenerative diseases that affect a number of structures and systems within the central and peripheral nervous system. Many of these can be included within the groups of synucleinopathies and tauopathies, although on occasions the pathological findings overlap between the two. Conclusions. Further knowledge of the functioning of the nervous system and the processes involved in neuronal degeneration is needed to be able to produce new, more effective therapeutic strategies (AU)


Subject(s)
Humans , Male , Female , Parkinson Disease/genetics , Parkinson Disease/metabolism , Tremor/pathology , Muscle Rigidity/physiopathology , Basal Ganglia/pathology , Motor Skills Disorders/physiopathology , Hypokinesia/diagnosis , Neurotransmitter Agents/administration & dosage , Nervous System Diseases/genetics , Parkinson Disease/pathology , Parkinson Disease/therapy , Tremor/metabolism , Muscle Rigidity/metabolism , Basal Ganglia/abnormalities , Motor Skills Disorders/therapy , Hypokinesia/complications , Neurotransmitter Agents , Nervous System Diseases/metabolism
6.
Rev Neurol ; 33(6): 505-10, 2001.
Article in Spanish | MEDLINE | ID: mdl-11727227

ABSTRACT

INTRODUCTION: The clinical picture and aetiology of intracranial venous thrombosis are highly variable. Early descriptions reported it as a rare disease with a poor prognosis but the advent of neuroimaging techniques, and a deeper knowledge of the clinical picture, have shown it to have a higher frequency and a better prognosis. OBJECTIVE: To report the clinical and neuroimaging findings in patients diagnosed as having intracranial venous thrombosis in our department and review the state of the literature. PATIENTS AND METHODS: We reviewed all discharge reports from patients admitted to the neurology department of the Juan Canalejo Hospital between 1975 and 2000. Of these, we reviewed the medical records of those patients diagnosed as having intracranial venous thrombosis in order to obtain data relating to the clinical manifestations, complementary tests, etiological and topographical diagnosis, treatment and outcome. RESULTS: Diagnosis of intracranial venous thrombosis was made in 16 patients. The most common symptom was headache. The superior sagittal was the most frequently affected sinus. In almost all patients CT results led to the suspicion, and in some cases the confirmation, of the diagnosis. The most frequently found aetiology was oral contraceptive consumption. Outcome was generally good both with anticoagulation and symptomatic treatments. CONCLUSIONS: The most important difference between the present study and earlier reports is in the frequency of the different aetiologies. Our findings provide further evidence that intracranial venous thrombosis is not an infrequent disease and that the prognosis is generally good.


Subject(s)
Brain/blood supply , Intracranial Thrombosis/physiopathology , Venous Thrombosis/physiopathology , Adult , Aged , Brain/diagnostic imaging , Cerebral Veins/diagnostic imaging , Female , Humans , Intracranial Thrombosis/complications , Intracranial Thrombosis/diagnosis , Male , Middle Aged , Tomography, X-Ray Computed , Venous Thrombosis/complications , Venous Thrombosis/diagnosis
7.
Int J Epidemiol ; 29(2): 369-75, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10817138

ABSTRACT

BACKGROUND: This study aimed to evaluate purified protein derivative (PPD) reactivity and its interrelationship with anergy panel and CD4+ lymphocytes in HIV-infected subjects as compared to PPD reactivity in HIV-uninfected individuals in a tuberculosis endemic and high Bacillus Calmette-Guérin (BCG) coverage environment. METHODS: Clients of four Mexico City HIV detection centres were screened for HIV-1 antibodies (ELISA or haemagglutination, Western Blot); reactivity to PPD (Mantoux PPD, 5TU RT-23), Candida (1:1000, 0.1 ml), and tetanus toxoid (10Lf, 0.1 ml); and CD4+ T cells. Active tuberculosis was excluded. Informed consent was obtained. RESULTS: From 5130 clients 1168 subjects were enrolled; of these 801 (68.6%) were HIV positive. Reactivity to PPD among HIV-positive subjects was found in 174 (22%), 261 (32.6%), and 296 (37%), at PPD cutoff levels of > or =10 mm, > or =5 mm, and > or =2 mm as compared to 224 (61%) of 367 HIV-negative individuals' reactors to PPD (> or =10 mm) (P < 0.001). After exclusion of anergic individuals using two cutoff levels for cutaneous allergens (< or =2 mm and < or =5 mm), PPD reactivity between HIV-infected and uninfected individuals continued to be significantly different. Only HIV-infected individuals with CD4+ T cells > or =500 cells/mm3 had similar reactivity to PPD as HIV-uninfected individuals. Variables associated with PPD reactivity were CD4+ T cell counts, BCG scar, HIV infection and age. CONCLUSIONS: PPD reactivity was useful to diagnose tuberculosis infection only among HIV-infected individuals with CD4+ counts > or =500 cells/mm3. Among individuals with lower counts, lowering cutoff levels or using anergy panel did not permit comparable reactivity as that observed among HIV-uninfected individuals.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Antibodies, Bacterial/analysis , Mycobacterium tuberculosis/immunology , Tuberculin Test , Tuberculosis, Pulmonary/epidemiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/microbiology , Adjuvants, Immunologic/therapeutic use , Adolescent , Adult , BCG Vaccine/therapeutic use , CD4 Lymphocyte Count , Female , HIV Antibodies/analysis , HIV-1/immunology , Humans , Male , Mexico/epidemiology , Prevalence , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/microbiology , Urban Population
8.
Int J Epidemiol ; 28(1): 135-40, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10195678

ABSTRACT

BACKGROUND: Tuberculosis (TB) rates remain high in regions of Southern Mexico despite the existence of a National Tuberculosis Program. Understanding TB epidemiology in such settings would assist in the design of improved TB control and highlight the challenges confronting TB control in developing countries. METHODS: We conducted a retrospective review of treatment control cards from 1991 to 1994 in five municipalities in a semiurban region of Southern Mexico. RESULTS: The relatively high rate of TB observed, 42.6 per 100,000 inhabitants, did not change significantly during the study period. Cure rates among new cases were 79% and significantly lower among retreatment cases (62%). Directly observed therapy (DOT) was administered to 84% of patients. Approximately one-half of the retreatment cases who were not cured were compliant with therapy, suggesting that drug resistance contributed to these poor results. Of particular concern was a core group of 16 patients who had received at least three treatments. CONCLUSIONS: This region of Mexico has persistently high TB rates despite a DOT-based TB control programme which achieves an overall cure rate of 77%. There exist many retreatment cases for whom cure rates are significantly lower. These cases may serve as a core group for the dissemination of drug resistant TB. The control programme is being reinforced by a nominal register of patients, decreasing administrative barriers for drug supply to individual patients and the availability of mycobacteria cultures. In addition to these measures, in regions which are approaching the levels of efficacy recommended by the WHO it may be appropriate to consider focusing efforts on the identification and treatment of chronic cases.


Subject(s)
Tuberculosis/prevention & control , Adolescent , Adult , Aged , Analysis of Variance , Child , Child, Preschool , Communicable Disease Control/organization & administration , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Mexico/epidemiology , Middle Aged , Odds Ratio , Population Surveillance/methods , Program Evaluation , Retrospective Studies , Treatment Outcome , Tuberculosis/epidemiology
9.
Salud Publica Mex ; 37(6): 539-48, 1995.
Article in Spanish | MEDLINE | ID: mdl-8599128

ABSTRACT

Tuberculosis (TB) still is an important health problem in Mexico. According to reported figures, an excess in the number of cases has occurred during recent years, mainly among young adults of both sexes. The present estimated rate of TB is 51.7 cases/100,000 inhabitants. This is the most frequent endemic infection among AIDS patients, ranking third among infectious diseases after candidiasis and P. carinii pneumoniae. A total of 8.3% of the 19,352 AIDS cases notified to July 1994, presented TB as the initial manifestation. According to sentinel surveillance carried out since 1990 in 17 states, HIV seroprevalence among TB patients has been 3.1% (0-6.5%) in males and 1.0% (0-2.3%) in females. Results of epidemiologic research in the field of TB prevention and characteristics of drug sensitivity of strains of M. tuberculosis isolated from HIV/AIDS patients are also described. Finally, perspectives of TB prevention and control are discussed.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , HIV-1 , Tuberculosis/epidemiology , AIDS-Related Opportunistic Infections/prevention & control , Adult , Child , Female , HIV Seropositivity/epidemiology , HIV Seroprevalence , Humans , Male , Mexico/epidemiology , Prevalence , Registries/statistics & numerical data , Sentinel Surveillance , Tuberculosis/prevention & control , Tuberculosis, Multidrug-Resistant/epidemiology
10.
Int J Epidemiol ; 21(4): 800-6, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1521986

ABSTRACT

In 1985, the Pan American Health Organization adopted the goal of eradication of poliomyelitis from the Americas by 1990. Strategies to accomplish this included high vaccination coverage, aggressive outbreak control, and active surveillance for acute flaccid paralysis (AFP). Although the sensitivity of AFP surveillance for detecting paralytic poliomyelitis cases is high, studies have shown the specificity to be low. In 1990, 2497 notified cases of AFP were investigated in the Americas of which 2146 had stool specimens collected. However, only 18 were confirmed as poliomyelitis by isolation of wild poliovirus from stool specimens, 71 were classified as being compatible with poliomyelitis. Cases of AFP due to causes other than poliomyelitis result in extensive but unnecessary outbreak control measures. To predict, at initial clinical evaluation, the likelihood of future confirmation as a case of poliomyelitis, likelihood ratios (LR) were calculated for different combinations of clinical characteristics of AFP cases (249) from Mexico in 1989 and 1990. The best predictors in a child with AFP were proximal muscle involvement which progressed '4 days together with fever at onset of paralysis, and proximal and unilateral involvement with either fever at onset or paralysis which progressed '4 days. The odds would increase by 12 that the child would eventually be confirmed as poliomyelitis (19), based on a stool culture positive for wild poliovirus (95% confidence interval (CI) 2.6-55.9). A guide for use in the field is proposed whereby local health officials, often with little training in neurological evaluation, can predict at initial clinical examination the likelihood that an AFP case will subsequently be confirmed as poliomyelitis.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Paralysis/microbiology , Poliomyelitis/diagnosis , Poliomyelitis/epidemiology , Adolescent , Child , Child, Preschool , Disease Outbreaks/prevention & control , Humans , Likelihood Functions , Mexico/epidemiology , Muscle Hypotonia/microbiology , Odds Ratio , Paralysis/physiopathology , Poliomyelitis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...